A groundbreaking study explored the immunomodulatory effects of PBDE-47, specifically examining its influence on macrophages, key players in our innate immune defense. Macrophages, crucial for identifying and clearing pathogens, can adopt different functional states, known as polarization (M1 and M2). This polarization is vital for orchestrating appropriate immune responses. The research revealed that PBDE-47 can alter the composition of extracellular vesicles (EVs) released by activated macrophages. EVs are tiny sacs released by cells that act as messengers, carrying various biomolecules, including microRNAs (miRNAs), to other cells.
The study demonstrated that PBDE-47 treatment led to significant changes in the miRNA content of these EVs. When these altered EVs, referred to as sEVsPBDE+LPS, were transferred to resting macrophages, they impacted the recipient cells' internal miRNA profiles. This cellular communication via EVs is a critical mechanism through which immune cells coordinate their activities. The research found that the sEVsPBDE+LPS treatment led to the downregulation of several miRNAs within the recipient macrophages, suggesting a potential rewiring of cellular regulatory pathways.
Furthermore, the study investigated the functional consequences of this EV-mediated communication. By analyzing specific surface markers on the macrophages, the researchers observed that PBDE-47, transmitted through EVs, significantly reduced the expression of HLA-DR and CD209. These markers are important for immune cell interaction and antigen presentation. The reduction in these markers suggests that PBDE-47 exposure, via its effect on EVs, may impair the macrophages' ability to effectively engage with other immune cells and initiate appropriate immune responses. This highlights a potential pathway through which environmental pollutants like flame retardants can compromise immune system integrity. Understanding these complex interactions is vital for developing strategies to mitigate the health risks associated with chemical exposures. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying high-quality chemicals for such critical research, contributing to advancements in toxicology and environmental health.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.